Department of Cardiothoracic and Vascular Surgery, Advanced Aortic Research Program at the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX.
Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, MA.
Ann Surg. 2023 Oct 1;278(4):e893-e902. doi: 10.1097/SLA.0000000000005859. Epub 2023 Apr 13.
To report mid-term outcomes of renal-mesenteric target arteries (TAs) after fenestrated-branched endovascular aortic repair (FB-EVAR) of complex abdominal and thoracoabdominal aortic aneurysm.
TA instability (TAI) is the most frequent indication for reintervention after FB-EVAR.
Data from consecutive patients enrolled in 9 prospective nonrandomized physician-sponsored investigational device exemption studies between 2005 and 2020 were reviewed. TA outcomes through 5 years of follow-up were analyzed for vessels incorporated by fenestrations or directional branches (DBs), including TA patency, endoleak, integrity failure, reintervention, and instability.
A total of 1681 patients had 6349 renal-mesenteric arteries were targeted using 3720 fenestrations (59%), 2435 DBs (38%), and 194 scallops (3%). Mean follow was 23 ± 21 months. At 5 years, TAs incorporated by fenestrations had higher primary (95 ± 1% vs 91 ± 1%, P < 0.001) and secondary patency (98 ± 1% vs 94 ± 1%, P < 0.001), and higher freedom from TAI (87 ± 2% vs 84 ± 2%, P = 0.002) compared with TAs incorporated by DBs, with no differences in other TA events. DBs targeted by balloon-expandable stent-grafts had significantly lower freedom from TAI (78 ± 4% vs 88 ± 1%, P = 0.006), TA endoleak (87 ± 3% vs 97 ± 1%, P < 0.001), and TA reintervention (83 ± 4% vs 95 ± 1%, P < 0.001) compared with those targeted by self-expandable stent-grafts.
Incorporation of renal and mesenteric TA during FB-EVAR is safe and durable with high 5-year patency rates and low freedom from TAI. DBs have lower patency rates and lower freedom from TAI than fenestrations, with better performance for self-expandable stent grafts as compared with balloon-expandable stent grafts.
报告复杂腹主动脉瘤和胸腹主动脉瘤的分支型腔内血管重建术(FB-EVAR)中肾-肠系膜靶动脉(TA)的中期结果。
TA 不稳定(TAI)是 FB-EVAR 后再次介入治疗的最常见指征。
回顾了 2005 年至 2020 年期间 9 项前瞻性非随机医师赞助的研究性器械豁免研究中连续入组患者的数据。分析了 5 年随访中纳入开窗或定向分支(DB)的血管的 TA 结局,包括 TA 通畅性、内漏、完整性失败、再介入和不稳定。
共 1681 例患者有 6349 支肾-肠系膜动脉,其中 3720 支采用开窗(59%),2435 支采用 DB(38%),194 支采用扇贝(3%)。平均随访时间为 23 ± 21 个月。5 年时,采用开窗技术的 TA 主要通畅率(95 ± 1%比 91 ± 1%,P < 0.001)和次要通畅率(98 ± 1%比 94 ± 1%,P < 0.001)较高,TAI 无复发率(87 ± 2%比 84 ± 2%,P = 0.002)也较高,而采用 DB 的 TA 则无明显差异。采用球囊扩张支架的 DB 的 TAI 无复发率(78 ± 4%比 88 ± 1%,P = 0.006)、TA 内漏(87 ± 3%比 97 ± 1%,P < 0.001)和 TA 再介入(83 ± 4%比 95 ± 1%,P < 0.001)明显较低。
FB-EVAR 中肾和肠系膜 TA 的融合是安全和持久的,5 年通畅率高,TAI 无复发率低。与开窗相比,DB 的通畅率较低,TAI 无复发率较低,而与球囊扩张支架相比,自膨式支架的性能更好。